Merck KGaA (OTCMKTS:MKGAF) Shares Gap Up – What’s Next?

Merck KGaA (OTCMKTS:MKGAF)’s stock price gapped up prior to trading on Tuesday. The stock had previously closed at $157.9690, but opened at $167.1350. Merck KGaA shares last traded at $167.5490, with a volume of 84 shares trading hands.

Merck KGaA Trading Up 6.7%

The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The business’s fifty day moving average is $159.57 and its 200 day moving average is $153.99. The stock has a market cap of $21.77 billion, a PE ratio of 25.72 and a beta of 0.96.

Hedge Funds Weigh In On Merck KGaA

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Elefante Mark B acquired a new stake in shares of Merck KGaA during the 2nd quarter valued at about $617,000. Ames National Corp bought a new stake in Merck KGaA in the 2nd quarter valued at $1,009,000. Notis McConarty Edward bought a new stake in Merck KGaA during the second quarter worth $1,304,000. North Star Asset Management Inc. bought a new stake in Merck KGaA in the 2nd quarter valued at $1,411,000. Finally, Pinnacle Holdings LLC bought a new position in shares of Merck KGaA in the second quarter worth $1,487,000. 0.10% of the stock is owned by institutional investors.

About Merck KGaA

Merck KGaA is a German science and technology company headquartered in Darmstadt, Germany. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. The company operates under the name EMD Serono in the United States and Canada, where the Merck name is associated with a separate company.

Merck KGaA operates through three primary business sectors: Healthcare, Life Science and Electronics. Its Healthcare business develops and markets prescription medicines, including treatments in oncology, neurology and immunology, as well as fertility and other specialty-care products.